Cargando…
A Case of Late-Onset Gemcitabine Lung Toxicity
Gemcitabine is a chemotherapeutic agent used for the treatment of a number of malignancies. Although its major dose-limiting side effect is myelosuppression, many pulmonary toxicities have been described with its use. Severe pulmonary toxicity is rare, but symptoms tend to be rapid in onset and pote...
Autores principales: | Sherrod, Amanda M., Brufsky, Adam, Puhalla, Shannon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117630/ https://www.ncbi.nlm.nih.gov/pubmed/21695101 http://dx.doi.org/10.4137/CMO.S6643 |
Ejemplares similares
-
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
por: Puhalla, Shannon, et al.
Publicado: (2008) -
Docetaxel/gemcitabine: Various toxicities: 4 case reports
Publicado: (2021) -
Late-onset toxic anterior segment syndrome after ICL implantation: two case reports
por: Li, Li, et al.
Publicado: (2023) -
Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease
por: Turco, Célia, et al.
Publicado: (2015) -
Three cases of late-onset oligomeganephronia
por: Kawanishi, Kunio, et al.
Publicado: (2011)